GlassScriptPhysician profile
Pedro P Maria
NPI 1740394618
$241,931.36
in general payments reported to CMS, 2019-2025
37 companies · $52K in 2025
The $52K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $8,984 · 2021: $21K · 2022: $7,238 · 2023: $53K · 2024: $61K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $123K · Travel and Lodging: $22K · Food and Beverage: $21K · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $122,942.27 |
| Travel and Lodging | $21,716.34 |
| Food and Beverage | $21,065.88 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $210,861.06 | 2019-2025 | Titan, Virtue, Coloplast Tfl Drive |
| Axogen | $9,081.48 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Davol INC. | $5,902.83 | 2020-2024 | Arista Ah Flexitip, Phasix Mesh |
| Kerecis Limited | $3,240.70 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Neotract INC. | $2,254.24 | 2019-2020 | |
| Boston Scientific Corporation | $1,819.20 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Teleflex LLC | $1,150.14 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $958.56 | 2020-2024 | Xiaflex, Edex, Aveed |
| Astellas Pharma US INC | $799.94 | 2019-2024 | Veozah, Myrbetriq |
| Becton, Dickinson and Company | $684.43 | 2025 | Arista, Avitene Ultrafoam |
| Ethicon US, LLC | $669.63 | 2019-2025 | Echelon Flex |
| Palette Life Sciences, INC. | $550.72 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $483.78 | 2023-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $401.36 | 2024-2025 | Cvac Aspiration System |
| Endo USA, INC. | $300.65 | 2024-2025 | Xiaflex, Aveed, Edex |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $297.65 | 2023 | Aquabeam Robotic System |
| Progenics Pharmaceuticals, INC. | $282.22 | 2023-2024 | Pylarify |
| Rigicon,INC. | $264.83 | 2022-2024 | Rigi10 Malleable Penile Prosthesis, Rigi10 Malleable Penile Prosthesis |
| Axonics, INC. | $248.70 | 2021-2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $233.11 | 2019 | |
| Pfizer INC. | $231.54 | 2020-2021 | |
| Medtronic, INC. | $203.90 | 2024 | Signia |
| Urogen Pharma, INC. | $175.16 | 2022 | |
| Karl Storz Lithotripsy-America | $150.00 | 2022 | |
| Contura, INC. | $139.96 | 2020 | |
| Angiodynamics, INC. | $132.23 | 2022 | |
| Ambu INC. | $89.31 | 2020-2021 | |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Laborie Medical Technologies Corp. | $45.46 | 2020 | |
| Dendreon Pharmaceuticals LLC | $44.66 | 2025 | Provenge |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $34.66 | 2022 | |
| Acerus Pharmaceuticals Corporation | $33.74 | 2022 | |
| Janssen Biotech, INC. | $24.98 | 2025 | Erleada |
| Avanos Medical | $24.41 | 2022 | |
| Intuitive Surgical, INC. | $17.09 | 2021 | |
| Tolmar, INC. | $13.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Maria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.